drugset / Trial / NCT01607411

A Clinical Study to Evaluate Experimental Children's Toothpastes in an In-Situ Caries Model

NCT01607411 ↗

Phase 3 Completed 55 enrolled GlaxoSmithKline
RandomizedCrossoverSingle-blindTreatment

Summary

An in situ model will be used to evaluate and compare enamel remineralization of human enamel specimens after single use of experimental children's toothpastes.

Timeline

Start
2012-02
Primary completion
2012-05
Completion
2012-05

Outcome

Met primary endpoint

registry NaF Toothpaste (1426 Ppm F) vs Placebo Toothpaste (0 Ppm F); p <0.0001; Adjusted Mean Difference 5.59 (95% CI 3.60 to 7.58) NCT01607411 ↗

registry NaF Toothpaste (1000 Ppm F) vs Placebo Toothpaste (0 Ppm F); p <0.0001; Adjusted Mean Difference 4.36 (95% CI 2.37 to 6.35) NCT01607411 ↗

registry NaF Toothpaste (500 Ppm F) vs Placebo Toothpaste (0 Ppm F); p = 0.0021; Adjusted Mean Difference 3.16 (95% CI 1.17 to 5.15) NCT01607411 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject sodium fluoride Unknown 500 ppm —
Subject sodium fluoride Unknown 1000 ppm —
Subject sodium fluoride Unknown 1426 ppm —

Indications